Medxy AI

Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

By MedXY 09/28/2026

A phase 2 clinical study demonstrates that lumacaftor safely shortens QTc in LQT2 patients with KCNH2 trafficking defects, supported by patient-specific cardiomyocyte models validating the mechanism.

Clinical Updates news Oncology Public Health

Disparities in Cancer Incidence by Sex and Associated Lifestyle Factors and Health Conditions: An Integrative Review

By MedXY 09/28/2026

This review analyzes global sex disparities in cancer incidence, highlighting modifiable lifestyle and health factors — notably smoking, alcohol, and obesity — as key contributors differing by population context, with implications for tailored prevention strategies.

Hematology-Oncology news Oncology

Precision Immunotherapy in Acute Myeloid Leukemia: Advancing Beyond Traditional Targets

By MedXY 09/28/2026

Recent advances in identifying leukemia-restricted antigens enable subtype-specific immunotherapies in AML that selectively target malignant cells while sparing normal hematopoiesis, offering a promising new paradigm for precision treatment.

Hematology-Oncology news

Targeting MERTK in CLL: A Promising Strategy for Overcoming Ibrutinib Resistance

By MedXY 09/28/2026

Aberrant MERTK expression activates BCR signaling via CD79a in CLL, offering a novel therapeutic target. Inhibiting MERTK with UNC-2025 shows potential against ibrutinib-resistant relapse, especially combined with venetoclax.

Hematology-Oncology news

Recombinant ADAMTS13 Therapy Demonstrates Superior Efficacy and Safety Over Plasma-Based Therapy in Congenital Thrombotic Thrombocytopenic Purpura: Final Phase 3 Trial Results

By MedXY 09/28/2026

Final phase 3 trial analysis confirms recombinant ADAMTS13 (rADAMTS13) provides effective prophylaxis with fewer acute and subacute TTP events and better safety than plasma-based therapy in congenital TTP patients.

Critical Care news Respiratory

Plasma sRAGE Biomarker Guides Personalized Lung Recruitment Strategies in ARDS: Insights from the LIVE Trial

By MedXY 09/28/2026

Baseline plasma sRAGE levels identify differential mortality benefits from lung recruitment in ARDS, enabling personalized ventilation strategies unlike inflammatory phenotyping. High sRAGE patients benefit from recruitment maneuvers, while low sRAGE patients face increased risk.

news Respiratory

Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: Robust Evidence from the Combined TETON-1 and TETON-2 Phase 3 Trials

By MedXY 09/28/2026

Combined analysis of the TETON-1 and TETON-2 trials confirms inhaled treprostinil significantly slows lung function decline, reduces clinical worsening and exacerbations, and improves quality of life in idiopathic pulmonary fibrosis over one year.

news Ophthalmology

Hess Screen Test: A Crucial Tool to Differentiate Decompensated Esophoria from Sagging Eye Syndrome

By MedXY 09/28/2026

This study demonstrates that the Hess Screen Test reveals greater esodeviation in decompensated esophoria compared to prism cover test measurements, effectively distinguishing it from sagging eye syndrome, with implications for diagnosis and surgical outcomes.

news Otorhinolaryngology

Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction

By MedXY 09/28/2026

Injection of botulinum toxin into the supraglottic region significantly reduces symptoms of laryngeal sensory dysfunction by targeting vagal nerve hypersensitivity, improving throat irritation without harming voice function.

news OB/GYN & Women's Health Oncology

Balancing Risks: The Impact of Bilateral Salpingo-Oophorectomy Timing on Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

By MedXY 09/28/2026

This article examines how the timing of bilateral salpingo-oophorectomy (BSO) affects the lifetime ovarian cancer risk in women carrying BRCA1 or BRCA2 mutations, emphasizing the benefits of preventive surgery and its residual risk reduction across different ages.

Neurology news Public Health

Long-Term Dementia Risk After TIA: A Population-Based Study Reveals Sustained Cognitive Threat

By MedXY 09/28/2026

A large Ontario cohort study found that transient ischemic attack (TIA) significantly increases long-term dementia risk, rivaling stroke's impact, underscoring the need for cognitive-focused prevention strategies.

Cardiology Diabetes & Endocrinology news

Unraveling the Cardiovascular Benefits of Semaglutide: Insights from the SELECT Trial Mediation Analysis

By MedXY 09/28/2026

The SELECT trial demonstrates semaglutide's 20% reduction in major cardiovascular events in adults with obesity and cardiovascular disease. Mediation analysis reveals partial but uncertain roles of weight, inflammation, and glycemic markers, highlighting the need for further mechanistic research.

news Ophthalmology

EYS-Associated Retinal Degeneration in South Korea: Insights into Genetic Variability, Clinical Features, and Disease Progression

By MedXY 09/28/2026

This comprehensive South Korean study characterizes the genetic landscape, clinical phenotype, and natural history of EYS-associated retinal degeneration, establishing progression benchmarks for future gene therapy trials.

General Surgery news Otorhinolaryngology

Evaluating Visual Parathyroid Identification During Thyroidectomy: Insights from Decision Curve Analysis

By MedXY 09/28/2026

A study assessing the diagnostic accuracy and clinical net benefit of visual parathyroid gland identification during thyroidectomy reveals limited specificity and highlights the need for adjunctive validation methods to enhance gland preservation.

Diabetes & Endocrinology General Surgery news

Evaluating the Impact of Parathyroidectomy and Bisphosphonate Therapy on Bone Mineral Density: Insights from a Multi-Institutional Study

By MedXY 09/28/2026

This study assesses how often parathyroidectomy yields clinically meaningful improvements in bone mineral density, with or without adjuvant bisphosphonate treatment in patients with primary hyperparathyroidism.

General Surgery news OB/GYN & Women’s Health

Assessing Transvaginal Drainage Versus Laparoscopy for Tubo-Ovarian Abscess: Insights from a Multicenter Randomized Trial

By MedXY 09/28/2026

This clinical trial compares ultrasound-guided transvaginal drainage to laparoscopy for tubo-ovarian abscess evacuation, highlighting differences in cure rates, reintervention frequency, and recovery outcomes.

news OB/GYN & Women’s Health Oncology

Innovative Phase II Trial of Carboplatin, Paclitaxel, and Pembrolizumab with HIPEC and Olaparib Maintenance in Advanced Epithelial Ovarian Cancer

By MedXY 09/28/2026

This phase II study evaluates pembrolizumab combined with carboplatin/paclitaxel and HIPEC in neoadjuvant therapy, followed by pembrolizumab maintenance with or without olaparib in advanced stage III/IV epithelial ovarian cancer patients.

news OB/GYN & Women's Health Public Health

Predicting Term Birth Among First Nations Women: Insights from a Queensland Cohort Study

By MedXY 09/28/2026

This study identifies key prenatal factors predicting term birth in First Nations nulliparous women and introduces a clinical scoring tool to estimate personalized term birth probabilities, highlighting opportunities for culturally appropriate antenatal interventions.

Gastroenterology Internal Medicine news

Unveiling the Role of Butyrylcholinesterase in Hepatic Fibrosis: A Novel Cholinergic Target in Liver Disease

By MedXY 09/28/2026

Butyrylcholinesterase (BuChE) modulates hepatic stellate cell activation by degrading acetylcholine, mitigating fibrogenesis via muscarinic receptor signaling and offering a new therapeutic target for liver fibrosis.

Neurology news Public Health

Rising Stroke Incidence in Young Adults: Evolving Risk Profiles and Mortality Trends from a Population-Based Study

By MedXY 09/28/2026

Stroke incidence among young adults aged 20-54 is increasing despite a modest decline in 30-day fatality, linked to growing prevalence of vascular risk factors and substance use. This population-based study underscores urgent preventive needs in this demographic.